Presubmission meeting with Health Canada

The INESSS welcomes invitations from manufacturers to participate as observers, in virtual mode, in presubmission meetings with Health Canada as part of the homologation process for their product.

Participation in this activity enables the INESSS to obtain information prior to receive a scientific evaluation application for this product.

Requirements

• The invitation must be sent by e-mail to the following address:inscription@inesss.qc.ca
• The date and time of the meeting, the name of the drug, and the proposed indication must be mentioned in the e-mail.
• The INESSS will evaluate the opportunity to participate in the meeting, and the manufacturer will be informed by e-mail, as soon as possible, of the names and titles of the people designated by the INESSS to participate.
• The invitation to the presubmission meeting, including login details and the manufacturer's presentation, should be sent in advance to those invited and to the following address: inscription@inesss.qc.ca

Further details
If you have any questions about this process, please contact the Secretariat de la Direction de l'évaluation des médicaments et des technologies à des fins de remboursement by e-mail at inscription@inesss.qc.ca